₹1.34
+₹0.03 (+2.29%)
Closed · As of 26 Aug 3:30 pm
Mkt Cap
₹252 Cr
P/E
134.00
ROE
0.25%
ROCE
0.13%
About Evexia Lifecare Ltd
Evexia Lifecare established in 1990, has built a strong legacy over the years, evolving into a diversified business entity. The company was listed on the Bombay Stock Exchange (BSE) in 1994, under the stock code 524444, marking a significant milestone in its journey. Initially, Evexia Lifecare ventured into various business sectors, including healthcare and wellness. The company developed and marketed a variety of products aimed at improving health, wellness, and nutrition. Over the years, Evexia expanded its reach and capabilities, gaining a reputation for quality in the health and wellness space. However, since 2020, the company has made a strategic shift in its business focus. Recognizing the growing demand and potential in the pharmaceutical sector, Evexia pivoted its operations toward the pharmaceutical industry. Specifically, the company began focusing on the trading of pharmaceutical chemicals, forging key partnerships with prominent companies in South India.With this move, the company appears to be positioning itself for long-term success in the pharmaceutical trading space while continuing to build on its legacy of adaptability and business growth.
Founded
1990
CEO
Jayesh R Thakkar
Employees
9
HQ
Ahmedabad, India
About Evexia Lifecare Ltd
Evexia Lifecare established in 1990, has built a strong legacy over the years, evolving into a diversified business entity. The company was listed on the Bombay Stock Exchange (BSE) in 1994, under the stock code 524444, marking a significant milestone in its journey. Initially, Evexia Lifecare ventured into various business sectors, including healthcare and wellness. The company developed and marketed a variety of products aimed at improving health, wellness, and nutrition. Over the years, Evexia expanded its reach and capabilities, gaining a reputation for quality in the health and wellness space. However, since 2020, the company has made a strategic shift in its business focus. Recognizing the growing demand and potential in the pharmaceutical sector, Evexia pivoted its operations toward the pharmaceutical industry. Specifically, the company began focusing on the trading of pharmaceutical chemicals, forging key partnerships with prominent companies in South India.With this move, the company appears to be positioning itself for long-term success in the pharmaceutical trading space while continuing to build on its legacy of adaptability and business growth.
Founded:1990
CEO:Jayesh R Thakkar
Employees:9
HQ:Ahmedabad, India
Finished Products
1Sale of Products
₹207.51CrRaw Materials
1Purchases
₹193.71Cr2Raw Mtls.Consumed
₹2.50CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹2
52W Low
₹0
Volume7.70M
Avg VolumeN/A
Beta0.46
Dividend Yield0.00%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
134.00x
Valuation
P/B Ratio
0.47x
Valuation
EPS
₹0.01
Valuation
Dividend Yield
0.00%
Valuation
ROE
0.25%
Profitability
ROCE
0.13%
Profitability
Revenue by Segment
Contribution & growth by business line
Trading of Chemical productRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
0.0%
International
0.0%
No geographic split data available
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
2.16x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
-9.3%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.